SUPN
Supernus Pharmaceuticals Inc
Price:  
27.58 
USD
Volume:  
328,096.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN WACC - Weighted Average Cost of Capital

The WACC of Supernus Pharmaceuticals Inc (SUPN) is 7.6%.

The Cost of Equity of Supernus Pharmaceuticals Inc (SUPN) is 8.75%.
The Cost of Debt of Supernus Pharmaceuticals Inc (SUPN) is 4.45%.

Range Selected
Cost of equity 7.70% - 9.80% 8.75%
Tax rate 22.30% - 23.90% 23.10%
Cost of debt 4.00% - 4.90% 4.45%
WACC 6.7% - 8.5% 7.6%
WACC

SUPN WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.7 0.77
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 9.80%
Tax rate 22.30% 23.90%
Debt/Equity ratio 0.27 0.27
Cost of debt 4.00% 4.90%
After-tax WACC 6.7% 8.5%
Selected WACC 7.6%